| Literature DB >> 26224083 |
Abstract
Behbehani and colleagues use mass cytometry to profile the heterogeneity of acute myeloid leukemia (AML ) as compared with normal hematopoiesis. By using this approach and characterizing leukemic stem cells, important differences in response to chemotherapy between AML subsets can potentially be explained and new targeted approaches considered.Entities:
Mesh：
Year: 2015 PMID： 26224083 DOI： 10.1158/2159-8290.CD-15-0905
Source DB: PubMed Journal: Cancer Discov ISSN： 2159-8274 Impact factor: 39.397